The Recall Desk
Severity pendingFDA (Drugs)·D-0353-2026·Announced 2026-02-18

UDENYCA (PEGFILGRASTIM-CBQV)

Pending LLM rewrite. Source: FDA_DRUG D-0353-2026.

Severity not yet assessed

We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.

Plain-English summary

Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.

The recalled product

Product
UDENYCA (PEGFILGRASTIM-CBQV)
Brand
UDENYCA
Manufacturer
McKesson

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Subset of Lot 2199821
  • Expires: 05/31/2027 Specific Serial Numbers being Recalled: 160R694TT06X
  • 1C74A686RPPG
  • 1W6A2M777N3V
  • 20825394KR8P
  • 242E2RK3EA92
  • 2DG49VH89EPG
  • 2WEA2ADK1P4H
  • 3KR2TVAG3VDH
  • 42M0V0G9PM84
  • 46E9XKDPTH1R
  • 4AM12WEAE48H
  • 4FGHR096DMNV
  • 4MWGWM991XNA
  • 4NEW8XD9DNM2
  • 4Y2PYDFN9YA1
  • 61EPX42R4K2A
  • 63FN9VW5CAV7
  • 69TG160DW2CV
  • 69XFP3TMTP7X

UPCs (1)

  • 0369448025632

Distribution

Distributed nationwide across the United States.